B19 parvovirus-induced anemia in a normal child. Initial bone marrow erythroid hyperplasia and response to intravenous immunoglobulin.
OBJECTIVE
Human B19 parvovirus infection may cause severe erythroid hypoplasia in patients with an underlying hemolytic anemia. We report a case of severe parvovirus-induced anemia with initial marrow erythroid hyperplasia in a child with no underlying hematologic disorder.


CONCLUSIONS
The patient's rapid hemoglobin recovery after treatment with i.v. immunoglobulin further supports this form of therapy for children with parvovirus-induced anemia.
Murray
J C
JC
Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Gresik
M V
MV
Leger
F
F
McClain
K L
KL
D000740:Anemia / Q000097:blood / Q000209:etiology* / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology*; D002648:Child; D016731:Erythema Infectiosum / Q000097:blood / Q000150:complications* / Q000473:pathology; D004912:Erythrocytes / Q000187:drug effects / Q000473:pathology*; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006965:Hyperplasia; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D016732:Parvovirus B19, Human
D006454:Hemoglobins; D016756:Immunoglobulins, Intravenous